These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38587019)

  • 1. Public health surveillance of new psychoactive substances: recent developments.
    Fitzgerald ND; Cottler LB; Palamar JJ
    Curr Opin Psychiatry; 2024 Jul; 37(4):270-276. PubMed ID: 38587019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency department visits due to new psychoactive substances and other illicit drugs in Taiwan: preliminary results of the Taiwan Emergency Department Drug Abuse Surveillance (TEDAS) project.
    Lin CC; Weng TI; Ng CJ; Shih CP; Hsu J; Liao YC; Yang CC; Fang CC;
    Clin Toxicol (Phila); 2022 Jun; 60(6):708-715. PubMed ID: 35315299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.
    Bijlsma L; Celma A; Castiglioni S; Salgueiro-González N; Bou-Iserte L; Baz-Lomba JA; Reid MJ; Dias MJ; Lopes A; Matias J; Pastor-Alcañiz L; Radonić J; Turk Sekulic M; Shine T; van Nuijs ALN; Hernandez F; Zuccato E
    Sci Total Environ; 2020 Jul; 725():138376. PubMed ID: 32298891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007-2014.
    Neicun J; Yang JC; Shih H; Nadella P; van Kessel R; Negri A; Czabanowska K; Brayne C; Roman-Urrestarazu A
    PLoS One; 2020; 15(10):e0241056. PubMed ID: 33125395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New psychoactive substances: challenges for drug surveillance, control, and public health responses.
    Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P
    Lancet; 2019 Nov; 394(10209):1668-1684. PubMed ID: 31668410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New psychoactive substances: An actual problem or an overestimated phenomenon?
    Vaiano F; Pascali JP; Bertol E
    Forensic Sci Int; 2019 Nov; 304():109941. PubMed ID: 31574421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hair Testing for Drugs of Abuse and New Psychoactive Substances in a High-Risk Population.
    Salomone A; Palamar JJ; Gerace E; Di Corcia D; Vincenti M
    J Anal Toxicol; 2017 Jun; 41(5):376-381. PubMed ID: 28334805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm.
    Sutherland R; Allsop S; Peacock A
    Curr Opin Psychiatry; 2020 Jul; 33(4):343-351. PubMed ID: 32250983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting novel psychoactive substances around the world.
    Salomone A; Vincenti M
    Curr Opin Psychiatry; 2024 Jul; 37(4):258-263. PubMed ID: 38818825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New psychoactive substances: concerted efforts and common legislative answers for stemming a growing health hazard.
    Zaami S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9681-9690. PubMed ID: 31799633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Festivals following the easing of COVID-19 restrictions: Prevalence of new psychoactive substances and illicit drugs.
    Rousis N; Bade R; Romero-Sánchez I; Mueller JF; Thomaidis NS; Thomas KV; Gracia-Lor E
    Environ Int; 2023 Aug; 178():108075. PubMed ID: 37399770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia: results from the Emerging Drugs Network of Australia - Victoria project 2020-2022.
    Syrjanen R; Greene SL; Weber C; Smith JL; Hodgson SE; Abouchedid R; Gerostamoulos D; Maplesden J; Knott J; Hollerer H; Rotella JA; Graudins A; Schumann JL;
    Int J Drug Policy; 2023 Dec; 122():104245. PubMed ID: 37944339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics in new psychoactive substance users: A single center study.
    Su YJ; Chen TH; Liao WH; Chang KS; Lai YC
    Medicine (Baltimore); 2023 Jun; 102(25):e34084. PubMed ID: 37352073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using biomarkers in wastewater to monitor community drug use: a conceptual approach for dealing with new psychoactive substances.
    Reid MJ; Baz-Lomba JA; Ryu Y; Thomas KV
    Sci Total Environ; 2014 Jul; 487():651-8. PubMed ID: 24412561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 18. Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA).
    Weber C; Smith JL; Soderstrom J; Burrows S; McCutcheon D; Oosthuizen F; Fatovich DM;
    Clin Toxicol (Phila); 2023 Jul; 61(7):500-508. PubMed ID: 37449677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
    Helander A; Bäckberg M; Beck O
    PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of urine from pooled urinals - a novel method for the detection of novel psychoactive substances.
    Archer JR; Hudson S; Wood DM; Dargan PI
    Curr Drug Abuse Rev; 2013 Jun; 6(2):86-90. PubMed ID: 24308525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.